Suppr超能文献

通过小分子降解剂对 HDAC 降解能力的化学生物组学探索。

Chemo-proteomics exploration of HDAC degradability by small molecule degraders.

机构信息

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

出版信息

Cell Chem Biol. 2021 Oct 21;28(10):1514-1527.e4. doi: 10.1016/j.chembiol.2021.07.002. Epub 2021 Jul 26.

Abstract

Targeted protein degradation refers to the use of small molecules that recruit a ubiquitin ligase to a target protein for ubiquitination and subsequent proteasome-dependent degradation. While degraders have been developed for many targets, key questions regarding degrader development and the consequences of acute pharmacological degradation remain, specifically for targets that exist in obligate multi-protein complexes. Here, we synthesize a pan-histone deacetylase (HDAC) degrader library for the chemo-proteomic exploration of acute degradation of a key class of chromatin-modifying enzymes. Using chemo-proteomics, we not only map the degradability of the zinc-dependent HDAC family identifying leads for targeting HDACs 1-8 and 10 but also explore important aspects of degrading epigenetic enzymes. We discover cell line-driven target specificity and that HDAC degradation often results in collateral loss of HDAC-containing repressive complexes. These findings potentially offer a new mechanism toward controlling chromatin structure, and our resource will facilitate accelerated degrader design and development for HDACs.

摘要

靶向蛋白降解是指利用小分子将泛素连接酶招募到靶蛋白上进行泛素化,随后被蛋白酶体依赖的降解。虽然已经开发出许多针对特定靶点的降解剂,但关于降解剂的开发以及急性药理学降解的后果,特别是对于存在于必需多蛋白复合物中的靶点,仍存在一些关键问题。在这里,我们合成了一个泛组蛋白去乙酰化酶(HDAC)降解剂文库,用于对一类关键染色质修饰酶的急性降解进行化学蛋白质组学研究。通过化学蛋白质组学,我们不仅可以对锌依赖性 HDAC 家族的可降解性进行绘图,从而确定靶向 HDACs 1-8 和 10 的先导化合物,还可以探索降解表观遗传酶的重要方面。我们发现细胞系驱动的靶标特异性,并且 HDAC 降解通常会导致包含 HDAC 的抑制性复合物的副产物丢失。这些发现可能为控制染色质结构提供了一种新的机制,并且我们的资源将有助于加速 HDAC 的降解剂设计和开发。

相似文献

1
Chemo-proteomics exploration of HDAC degradability by small molecule degraders.通过小分子降解剂对 HDAC 降解能力的化学生物组学探索。
Cell Chem Biol. 2021 Oct 21;28(10):1514-1527.e4. doi: 10.1016/j.chembiol.2021.07.002. Epub 2021 Jul 26.
4
5
Designing HDAC-PROTACs: lessons learned so far.设计 HDAC-PROTACs:迄今为止的经验教训。
Future Med Chem. 2022 Jan;14(3):143-166. doi: 10.4155/fmc-2021-0206. Epub 2021 Dec 24.

引用本文的文献

2

本文引用的文献

3
Proteomics-Based Identification of DUB Substrates Using Selective Inhibitors.基于蛋白质组学的选择性抑制剂鉴定 DUB 底物。
Cell Chem Biol. 2021 Jan 21;28(1):78-87.e3. doi: 10.1016/j.chembiol.2020.09.005. Epub 2020 Oct 1.
8
Dichotomous engagement of HDAC3 activity governs inflammatory responses.HDAC3活性的二元参与调控炎症反应。
Nature. 2020 Aug;584(7820):286-290. doi: 10.1038/s41586-020-2576-2. Epub 2020 Aug 5.
10
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.三十年 HDAC 抑制剂:2020 年的新视角和新认识。
J Med Chem. 2020 Nov 12;63(21):12460-12484. doi: 10.1021/acs.jmedchem.0c00830. Epub 2020 Jul 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验